Most patients simply notice a lack of appetite suppression effect and recognize the dose was ineffective
GLP-1 agonists, such as Wegovy, have been shown to suppress appetite, which may lead to decreased food intake
[DOI] [PubMed] [Google Scholar] 120.Bays H.E., Burridge K., Richards J., Fitch A
Yes and this is the piece most patients are never told
STAT News cited a recently published British Medical Journal review of 37 studies, tallying an aggregate of more than 9,300 participants, in which approximately 50% of the people who started on the drugs stop taking them within one year
There are now more than a dozen approved GLP-1 drugs, some in pill form, and there are newer versions on the way